List of insiders holdings for CONDUIT PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Heilbron Jack Kendrick Murphy Canyon Acquisition Sponsor LLC Former CEO,director&10% owner | 2023-09-29 16:30:08 | 4,724,250 0 | 4,724,250 | Form 13D |
Lewis-Hall Freda C Director | 2024-11-20 16:30:11 | 437,976 2,520,311 | 2,958,287 | Form 4 |
Regan Andrew Corvus Capital Ltd. Algo Holdings Inc. Director 10% Owner | 2024-09-19 17:01:44 | 66,650 2,377,627 | 2,444,277 | Form 4 |
Nirland Ltd Stockton Ltd Rowland Master Trust Dovet Ltd 10% Owner | 2024-10-18 16:15:06 | 2,000,000 0 | 2,000,000 | Form 13G |
Bligh James Interim CFO | 2024-11-20 16:30:06 | 1,890,000 0 | 1,890,000 | Form 4 |
Tapolczay David Chief Executive Officer | 2024-11-20 16:30:09 | 840,000 0 | 840,000 | Form 4 |
Shaolin Capital Management LLC 10% Owner | 2023-02-16 17:28:28 | 609,750 0 | 609,750 | Form 13D |
Lewis-Hall Freda C Intelmed LLC Director | 2024-04-24 17:00:18 | 0 504,061 | 504,061 | Form 4 |
Farley Chele Chiavacci Director | 2024-11-20 16:30:08 | 351,510 0 | 351,510 | Form 4 |
Charles Faith L. Director | 2024-11-20 16:30:05 | 341,594 0 | 341,594 | Form 4 |
Feinberg Richard Edward Director | 2022-02-11 16:30:37 | 0 0 | 0 | Form 3 |
Bentzen Edwin H IV Chief Accounting Officer | 2022-02-11 16:30:48 | 0 0 | 0 | Form 3 |
Francis Knuettel II Director | 2022-02-11 16:31:00 | 0 0 | 0 | Form 3 |
McNealey Jennifer Isacoff Director | 2024-05-15 16:30:47 | 0 0 | 0 | Form 4 |
Sragovicz Adam Chief Financial Officer | 2024-05-15 16:30:49 | 0 0 | 0 | Form 4 |